News Biomaterials & Biomolecular Systems

  • ERC Advanced Grants will provide funding for ground-breaking research projects at TUM. These include a digital lung model that could represent a decisive step toward personalized medicine. Image: Jakob Richter / Ebenbuild / TUM

    EU funding for cutting-edge research

    27 April 2021 |  Four ERC Advanced Grants for TUM scientists. Two of them for the MSB-PIs Hendrik Dietz and Wolfgang Wall. 

  • Prof. Oliver Lieleg and Ceren Kimna are conducting research on nanoparticles that release drugs precisely into the affected cells. Image: Uli Benz / TUM

    Nanoparticles with synthetic DNA can control release of drugs

    Secure nano-carrier delivers medications directly to cells

    29 September 2020 | Nanoparticles with synthetic DNA can control release of drugs to reduce unwanted side-effects of medications

  • Cell cluster and fluorescent (red) nano switches. Image: Benjamin Kick, Klaus Wagenbauer, Jonas Funke / TUM

    Switch for antibodies to reduce side-effects in modern cancer therapies

    Activating medications with DNA

    20 July 2020 | As part of the LOGIBODY project, TUM researchers develop a DNA nanoswitch to reduce side-effects of cancer therapies 

  • Logo of the Virofight consortium. It shows a drawing of a virus enclosed in a hexagon. The inscription underneath says "Novel nano-technology to contain viruses"

    European research consortium VIROFIGHT to advance novel treatment against viruses

    Fighting viral infections with engulfing nano-shells

    13 July 2020 | European research consortium VIROFIGHT to advance novel treatment against viruses such as SARS-CoV-2, HIV, influenza and hepatitis viruses.

  • The lubrication technology for the implant will be based on the interaction between different kinds of polymer molecules. While molecules of one kind will be attached to the inner surface of the implant, others will be dispersed in the fluid. Image: Maria Bauer / TUM

    EU supports development of novel implantation techniques for finger joints affected by osteoarthritis

    Restoring Mobility to Finger Joints

    03 Jan 2020 | Seven partners collaborating in the European research project APRICOT aim to develop a radically new type of implant for the treatment of osteoarthritis of small joints in the hand.

  • EU flag and ERC logo

    ERC consolidator grant awarded to MSB-PI Gil Westmeyer

    Visualizing neuronal information processing

    11 Dec 2019 | ERC consolidator grant awarded to MSB-PI Gil Westmeyer for a project on the direct visualization of molecular states of neurons.

  • The Logibody team at the award ceremony.

    Research team mentored by MSB-PI Hendrik Dietz receives m4 Award

    Developing a nanoswitch for antibodies

    25 Oct 2019 | A research team mentored by MSB-PI Hendrik Dietz has received a m4 Award. They have developed a nanoswitch made from DNA that will allow immunotherapies against cancer to target tumors more specifically.

  • Two kinds of nanocompartments with different sizes that contain metal particles and thus can be easily distinguished in an Electron Microscopy.  Image: B. van Rossum / FMP

    Shape is the new color

    08 August 2019 | Self-assembling nanoparticles mark cells in electron microscopy.

  • Prof. Oliver Lieleg and PhD student Ceren Kimna use balls and pipe cleaners in different colors to visualize how nanoparticles can be bound together by DNA fragments. Such connections may become the basis of drugs that release their active ingredients in sequence. Image: Uli Benz / TUM

    Artificial DNA can control release of active ingredients from drugs

    01 July 2019 | A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was once a pharmacologist's dream is now much closer to reality. With a combination of hydrogels and artificial DNA, nanoparticles can be released in sequence under conditions similar to those in the human body.